VNRX today
$0.20+$0.02 (+10.41%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourStrong Bullish
15 minStrong Bullish
5 minStrong Bullish
Daily trend turns up above $0.19
Key levels
Resistance$0.26
Resistance$0.23
Support$0.19
Support$0.16
Latest news & SEC filings
EarningsVolitionRx Limited Sets Third Quarter 2026 Earnings Call and Business Update
DealVolitionRx pays $500,000 toward convertible note early
DealVolitionRx and Missionpharma Reach Early Agreement on NETosis Lateral Flow Technology
SEC FilingVolitionrx Ltd filed a report on a major company event (Form 8-K)
All VNRX news →About VolitionRx
VolitionRx is a multinational epigenetics company that develops blood tests using nucleosome and transcription factor biomarkers. Its product lines include Nu.Q Vet for cancer screening in dogs, Nu.Q NETs for sepsis and NETosis-related conditions, Nu.Q Discover for nucleosome profiling, Nu.Q Cancer for human cancer detection and monitoring, and Capture-PCR/Capture-Seq for isolating tumor-derived DNA. It operates laboratories and offices in Belgium, the United States, and the United Kingdom, and sells through distributors and licensing partners in human and veterinary diagnostics worldwide.
Based on the company's 10-K filed Mar 31, 2026.
NYSE · Healthcare
VOLITIONRX LTD (VNRX)
What Is the Price Target for VNRX?
SEPT Low Target
$1.00
SEPT Mid Target
$1.00
SEPT High Target
$1.00
Analyst Consensus
$1.00
Is VNRX a Buy or Sell Right Now?
Thesis
- •Revenue growing 40.0% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VNRX.
Start Free Trial →Is VNRX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$1.00
30
Moat Score
NONE
2/9
Piotroski Score
-62.9
Altman Z-Score
What Is Smart Money Doing with VNRX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Batchelor Ann-Louise | officer | Buy | 12,000 | - | Oct 21, 2026 |
| Forterre Gael | officer | Sale | 284 | $71.82 | Sep 28, 2026 |
| Michel Gaetan | officer | Sale | 608 | $153.76 | Sep 28, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →VNRX Growth Story
Revenue YoY
40.0%
3yr Revenue CAGR
78.0%
EPS Growth YoY
N/A
FCF Growth YoY
24.4%
Revenue Trend
STRONG
Dark Pool Trades for VNRX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for VNRX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 12:32:57 | $0.20 | 3,254 | $$660 | SELL |
| 12:32:23 | $0.20 | 4,390 | $$890 | SELL |
| 09:00:23 | $0.20 | 5,500 | $$1K | SELL |
| 23:35:18 | $0.19 | 1,000 | $$194 | SELL |
| 23:11:11 | $0.20 | 12,750 | $$3K | SELL |
5 dark pool trades shown · $$5K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for VOLITIONRX LTD (VNRX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →VNRX — frequently asked questions
What is VNRX stock price today?
VOLITIONRX LTD (VNRX) is at $0.20, up 10.41% (+$0.02) at the Nov 11, 2026 close.
Why is VNRX stock moving today?
Latest VNRX news — Nov 11, 2026: VolitionRx Limited Sets Third Quarter 2026 Earnings Call and Business Update · Oct 28, 2026: VolitionRx pays $500,000 toward convertible note early
What is the VNRX price target?
The average analyst price target for VNRX is $1.00, ranging from $1 to $1, based on 1 analysts. Latest: HC Wainwright & Co. maintains on Apr 2, 2026.
What do analysts rate VNRX?
Analyst ratings for VNRX: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did VNRX beat earnings?
VNRX last reported on Aug 13, 2026: EPS -$0.85 vs -$0.57 expected — a miss of 49.8%.
Does VNRX pay a dividend?
VNRX does not currently pay a dividend.
How much debt does VNRX have?
VOLITIONRX LTD reported $7M of debt and $3M of cash (Jun 30, 2026).
What are VNRX support and resistance levels?
Support: $0.19, $0.16. Resistance: $0.23, $0.26, $0.69.
What are insiders doing with VNRX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on VNRX?
Nov 11, 2026: VolitionRx Limited Sets Third Quarter 2026 Earnings Call and Business Update · Oct 28, 2026: VolitionRx pays $500,000 toward convertible note early · Oct 28, 2026: VolitionRx and Missionpharma Reach Early Agreement on NETosis Lateral Flow Technology